Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LGMN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XRN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCJ-SCHIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAMD1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHGC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPIDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADPRM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDSR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIGYF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on